Leuprorelin acetate April 13, 2017 Leuprorelin acetate Trade Name Orphan Indication Congenital hypogonadotropic hypogonadism EU Market Approval EU EU Designation Date 2017-01-12 00:00:00 Sponsor Stichting Centre for Human Drug Research (CHDR)
